Cyclophosphamide-Busulfan Instead of Busulfan-Cyclophosphamide for Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation

被引:0
|
作者
Cantoni, Nathan [1 ]
Gerull, Sabine [1 ]
Heim, Dominik [1 ]
Halter, Joerg [1 ]
Tsakiris, Dimitrios [1 ]
Bucher, Christoph [1 ]
Rovo, Alicia [1 ]
Arber, Caroline [1 ]
Buser, Andreas S. [1 ]
Passweg, Jakob R. [1 ]
Tichelli, Andre [1 ]
Stern, Martin [1 ]
Gratwohl, Alois [1 ]
机构
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:894 / 894
页数:1
相关论文
共 50 条
  • [41] Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation
    Goekkurt, Eray
    Stoehlmacher, Jan
    Stueber, Christian
    Wolschke, Christine
    Eiermann, Thomas
    Iacobelli, Simona
    Zander, Axel R.
    Ehninger, Gerhard
    Kroeger, Nicolaus
    ANTICANCER RESEARCH, 2007, 27 (6C) : 4377 - 4380
  • [42] BUSULFAN AND CYCLOPHOSPHAMIDE FOR PRETRANSPLANT CONDITIONING
    SHAW, PJ
    STEVENS, MM
    BONE MARROW TRANSPLANTATION, 1988, 3 (04) : 367 - 367
  • [43] BUSULFAN/CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA
    ODONNELL, MR
    LONG, GD
    PARKER, PM
    NILAND, J
    NADEMANEE, A
    AMYLON, M
    CHAO, N
    NEGRIN, RS
    SCHMIDT, GM
    SLOVAK, ML
    SMITH, EP
    SNYDER, DS
    STEIN, AS
    TRAWEEK, T
    BLUME, KG
    FORMAN, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) : 2973 - 2979
  • [45] Cyclophosphamide followed by Intravenous Targeted Busulfan for Allogeneic Hematopoietic Cell Transplantation: Pharmacokinetics and Clinical Outcomes
    Rezvani, Andrew R.
    McCune, Jeannine S.
    Storer, Barry E.
    Batchelder, Ami
    Kida, Aiko
    Deeg, H. Joachim
    McDonald, George B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) : 1033 - 1039
  • [46] OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER CONDITIONING WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE
    Ayas, Mouhab
    Belgaumi, Assim
    Al-Seraihy, Amal
    Al-Jefri, Abdullah
    Al-Ahmari, Ali
    Al-Mahr, Mohammed
    Khairy, Ashraf
    Markiz, Samer
    El-Soth, Hassan
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 816 - 816
  • [47] Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X-linked adrenal cerebral leukodystrophy
    Chen, Yao
    Xu, Lan-ping
    Zhang, Xiao-hui
    Chen, Huan
    Liu, Kai-yan
    Qing, Jiong
    Yang, Yan-ling
    Huang, Xiao-jun
    PEDIATRIC TRANSPLANTATION, 2024, 28 (03)
  • [48] Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
    Bornhäuser, M
    Storer, B
    Slattery, JT
    Appelbaum, FR
    Deeg, HJ
    Hansen, J
    Martin, PJ
    McDonald, GB
    Nichols, WG
    Radich, J
    Woolfrey, A
    Jenke, A
    Schleyer, E
    Thiede, C
    Ehninger, G
    Anasetti, C
    BLOOD, 2003, 102 (03) : 820 - 826
  • [49] REGIMEN-RELATED TOXICITY OF A BUSULFAN-CYCLOPHOSPHAMIDE CONDITIONING REGIMEN IN 70 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NEVILL, TJ
    BARNETT, MJ
    KLINGEMANN, HG
    REECE, DE
    SHEPHERD, JD
    PHILLIPS, GL
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1224 - 1232
  • [50] Characteristics of two conditioning regimens cyclophosphamide plus antithymocyte globulin versus cyclophosphamide plus busulfan in allogeneic stem cell transplantation for severe aplastic anemia
    Ommati, L. V. M.
    Silva, A. P.
    Silva, L. P.
    Faria, J. R.
    Chaufaille, M. d. L. F.
    Oliveira, J. S. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 95 - 96